These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38328854)

  • 1. Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
    Galtier J; Drevon L; Le Bris Y; Giraudier S; Wemeau M; Legros L; Paz DL; Girodon F; Kiladjian JJ; Mesguich C; Parrens M; Mediavilla C; Roy L; Guy A; Mansier O; Ianotto JC; James C
    Haematologica; 2024 Jun; 109(6):1989-1993. PubMed ID: 38328854
    [No Abstract]   [Full Text] [Related]  

  • 2. Red cell mass measurement is still useful for the management of myeloproliferative neoplasms. Comment to "Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs".
    Maaziz N; Girodon F
    Haematologica; 2024 Sep; 109(9):3081-3082. PubMed ID: 38695122
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocytes from patients with myeloproliferative neoplasms and splanchnic venous thrombosis show greater expression of Lu/BCAM.
    Novitzky-Basso I; Spring F; Anstee D; Tripathi D; Chen F
    Int J Lab Hematol; 2018 Aug; 40(4):473-477. PubMed ID: 29756283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes.
    Kanellopoulou T; Alexopoulou A; Koskinas J
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1382-3. PubMed ID: 21569067
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.
    How J; Trinkaus KM; Oh ST
    Br J Haematol; 2018 Oct; 183(2):310-313. PubMed ID: 29048104
    [No Abstract]   [Full Text] [Related]  

  • 6. High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
    Rosti V; Bonetti E; Bergamaschi G; Campanelli R; Guglielmelli P; Maestri M; Magrini U; Massa M; Tinelli C; Viarengo G; Villani L; Primignani M; Vannucchi AM; Frassoni F; Barosi G;
    PLoS One; 2010 Dec; 5(12):e15277. PubMed ID: 21151606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2V617F mutation in patients with splanchnic vein thrombosis.
    Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
    Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
    Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
    J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.
    Cattaneo D; Gianelli U; Bianchi P; Cortelezzi A; Iurlo A
    Eur J Intern Med; 2018 Jun; 52():e25-e26. PubMed ID: 29567096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
    Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
    Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder].
    Casadevall N; Valla D
    Rev Prat; 2005 Oct; 55(15):1669-70. PubMed ID: 16334203
    [No Abstract]   [Full Text] [Related]  

  • 12. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.
    Lavu S; Szuber N; Mudireddy M; Yogarajah M; Gangat N; Pardanani A; Hanson CA; Ketterling RP; Ashrani AA; Kamath PS; Tefferi A
    Am J Hematol; 2018 Mar; 93(3):E61-E64. PubMed ID: 29194707
    [No Abstract]   [Full Text] [Related]  

  • 13. Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.
    Waiswa M; Seremba E; Ocama P; Ddungu H; Opio K; Okello C; O'shea T; Verhovsek M; Mutyabule R
    Afr Health Sci; 2014 Dec; 14(4):1069-73. PubMed ID: 25834519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic vein thrombosis in myeloproliferative neoplasms.
    Sekhar M; McVinnie K; Burroughs AK
    Br J Haematol; 2013 Sep; 162(6):730-47. PubMed ID: 23855810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
    Pieri L; Paoli C; Arena U; Marra F; Mori F; Zucchini M; Colagrande S; Castellani A; Masciulli A; Rosti V; De Stefano V; Betti S; Finazzi G; Ferrari ML; Rumi E; Ruggeri M; Nichele I; Guglielmelli P; Fjerza R; Mannarelli C; Fanelli T; Merli L; Corbizi Fattori G; Massa M; Cimino G; Rambaldi A; Barosi G; Cazzola M; Barbui T; Vannucchi AM
    Am J Hematol; 2017 Feb; 92(2):187-195. PubMed ID: 27880982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies.
    Kiladjian JJ; Cassinat B
    Am J Hematol; 2023 May; 98(5):794-800. PubMed ID: 36869873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thrombophilia in splanchnic vein thrombosis.
    Primignani M; Mannucci PM
    Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder.
    Gianotti R; Charles H; Hymes K; Chandarana H; Sigal S
    World J Gastroenterol; 2014 Oct; 20(39):14495-9. PubMed ID: 25339837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.
    Tondeur S; Boutruche S; Biron-Andréani C; Schved JF
    Thromb Haemost; 2009 Apr; 101(4):787-9. PubMed ID: 19350131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.